Reperio Health provides an at-home health assessment solution to identify risk factors for preventable chronic conditions like heart disease and diabetes. Its patented technology allows individuals to perform biometric screenings in the comfort of their own homes, and receive results immediately via Bluetooth-connected devices.
The service includes an FDA-approved health kit that conducts blood tests to assess 10 different biometric indicators, such as blood pressure, cholesterol, glucose levels, body mass index, and relative fat mass. Additionally, Reperio offers 24/7 live support to its users.
Key customers and partnerships
The company operates a D2C and B2B2C business model offering their services via healthcare providers and employers. Key partners include Intel, Vitality, and Children’s Hospital Colorado.
In December 2023, the company reported over 500% YoY growth, with more than two dozen new clients representing over 40,000 contracted screenings.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.